Skip to content
Clinical Trials – home

DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): A Comprehensive Guide for Patients

1 / 1
trials open to patients / all trials
8+
Countries

In short

This article discusses the use of drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in clinical trials for advanced prostate cancer. These trials aim to evaluate the safety, efficacy, and potential benefits of combining these medications with other treatments for patients with metastatic castration-resistant prostate cancer (mCRPC). The research focuses on exploring new treatment options and improving outcomes for patients with this challenging form of cancer.

At a glance

Study Type
Phase 1/2 Umbrella Substudy
Target Condition
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Main Objectives
Evaluate safety, tolerability, and establish RP2D; Estimate PSA response rate
Key Inclusion Criteria
Confirmed mCRPC, prior NHA treatment, evidence of disease progression
Key Exclusion Criteria
Active CNS metastases, unstable cardiovascular disease, active autoimmune disease
Primary Endpoints
DLTs, AEs, treatment discontinuation due to AEs, PSA response rate
Secondary Endpoints
ORR, rPFS, OS, DOR, TFST, TTPP
Drug Category
Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (GORD)
Administration Route
Antegrade Epicardial Coronary Artery Infusion

Introduction to GORD Medications

Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) are a group of medications designed to treat conditions affecting the upper digestive system. These medications play a crucial role in managing symptoms and promoting healing in patients suffering from various gastrointestinal disorders.

What Are Drugs for Peptic Ulcer and GORD?

Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) are a class of medications specifically formulated to address issues in the stomach and esophagus. These drugs work by reducing acid production in the stomach or protecting the lining of the digestive tract.

Conditions Treated

While the primary focus of these medications is on peptic ulcers and GORD, they may also be used to treat or manage other related conditions. Some of the main conditions these drugs address include:

  • Peptic Ulcers: Open sores that develop on the inside lining of the stomach and the upper portion of the small intestine.
  • Gastro-oesophageal Reflux Disease (GORD): A chronic condition where stomach acid frequently flows back into the esophagus, causing irritation and discomfort.
  • Acid Reflux: A common condition where stomach acid flows back into the esophagus, causing heartburn and other symptoms.
  • Erosive Esophagitis: Inflammation and damage to the lining of the esophagus caused by stomach acid.

How These Drugs Are Administered

According to the clinical trial information, these drugs can be administered through various routes. One mentioned method is antegrade epicardial coronary artery infusion. However, it's important to note that this is an unusual route for GORD medications and may be specific to the research context. More common routes of administration for GORD drugs include:

  • Oral tablets or capsules
  • Liquid formulations
  • Intravenous injections (in hospital settings)

The specific route of administration will depend on the particular drug, the severity of the condition, and the patient's individual needs.

Current Research and Clinical Trials

While the clinical trial data provided doesn't specifically focus on GORD medications, it's worth noting that research in this field is ongoing. Clinical trials often explore new formulations, combinations, or applications of existing drugs to improve treatment outcomes for patients with gastrointestinal disorders.

Important Considerations for Patients

When taking drugs for peptic ulcer and GORD, patients should keep the following in mind:

  1. Follow prescribed dosage: Always take the medication as directed by your healthcare provider.
  2. Be aware of potential side effects: While generally well-tolerated, these drugs may cause side effects in some patients.
  3. Inform your doctor about other medications: Some GORD drugs may interact with other medications.
  4. Lifestyle modifications: In addition to medication, lifestyle changes such as dietary adjustments and weight management may be recommended.
  5. Regular follow-ups: Maintain regular check-ups with your healthcare provider to monitor your condition and adjust treatment if necessary.

Remember, while drugs for peptic ulcer and GORD can be highly effective in managing symptoms and promoting healing, they should always be used under the guidance of a healthcare professional. If you have any concerns or questions about your medication, don't hesitate to consult with your doctor or pharmacist.

Questions people often ask

Conditions where Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) is being studied

Each condition opens its own overview and trial list

Trials with Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.